Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion

Virology

Volumn 234, Issue 1, 1997, Pages 1-13

  Erickson, Kimberly D ^a   Martin, Jennifer M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRION; VIRUS CELL INTERACTION;

HUMAN HERPESVIRUS 4;

EID: 0031582640     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8638     Document Type: Article

References (41)

1. Baichwal V. R., Sugden B. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J. Virol. 61:1987;866-875.
2. Baichwal V. R., Sugden B. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene. 2:1988;461-467.
3. Baichwal V. R., Sugden B. The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene. 4:1989;67-74.
4. Beersma M. F. C., Bijlmakers M. J. E., Ploegh H. L. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:1993;4455-4464.
5. Boos H., Berger R., Kuklik-Roos C., Iftner T., Mueller-Lantzch N. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. Virology. 159:1987;161-165.
6. Bornkamm G. W., Hudewentz J., Freese U. K., Zimber U. Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region. J. Virol. 43:1982;952-968.
7. del Val M., Hengel H., Hacker H., Hartlaub U., Ruppert T., Lucin P., Koszinowski U. H. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J. Exp. Med. 176:1992;729-738.
8. Fennewald S., van Santen V., Kieff E. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51:1984;411-419.
9. Hammerschmidt W., Sugden B., Baichwal V. R. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63:1989;2469-2475.
10. Hammerskjold M., Simurda M. Epstein-Barr latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NFkB activity. J. Virol. 66:1992;6496-6501.
11. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 Expression by Epstein-Barr Virus Latent Membrane Protein 1 Protects Infected B Cells from Programmed Cell Death. Cell. 65:1991;1107-1115.
12. Hennessy K., Fennewald S., Hummel M., Cole T., Kieff E. A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc. Natl. Acad. Sci. USA. 81:1984;7207-7211.
13. Hudson G. S., Farrell P. J., Barrell B. G. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J. Virol. 53:1985;528-535.
14. Huen D. S., Henderson S. A., Croom-Carter D., Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 10:1995;549-560.
15. Kaye K. M., Izumi K. M., Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte transformation. Proc. Natl. Acad. Sci. USA. 90:1993;9150-9154.
16. Laherty C. D., Hu H. M., Opipari A. W., Wang F., Dixit V. M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kB. J. Biol. Chem. 34:1992;24157-24160.
17. Lamb R. A., Holsinger L. J., Pinto L. H. The Influenza A Virus M2 Ion Channel Protein and Its Role in the Influenza Virus Life Cycle. Cellular Receptors for Animal Viruses. 1994;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 303-321.
18. Liebowitz D., Kopan R., Fuchs E., Sample J., Kieff E. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol. Cell. Biol. 7:1987;2299-2308.
19. Liebowitz D., Wang D., Kieff E. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol. 58:1986;233-237.
20. Longnecker R., Druker B., Roberts T. M., Kieff E. An Epstein-Barr Virus Protein Associated with Cell Growth Transformation Interacts with a Tyrosine Kinase. J. Virol. 65:1991;3681-3692.
21. Mann K. P., Staunton D., Thorley-Lawson D. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55:1985;710-720.
22. Mann K. P., Thorley-Lawson D. Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein. J. Virol. 61:1987;2100-2108.
23. Martin J. M., Sugden B. The LMP onco-protein resembles activated receptors in its properties of turnover. Cell Growth Diff. 2:1991a;653-660.
24. Martin J. M., Sugden B. Transformation by the LMP onco-protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J. Virol. 65:1991b;3246-3258.
25. Miller C. L., Lee J. H., Kieff E., Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. USA. 91:1994;772-776.
26. Miller G. Epstein-Barr Virus. Fields B. N. Virology. 1985;Raven Press, NY.
27. Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:1973;190-194.
28. Mitchell T., Sugden B. Stimulation of NF-kB Mediated Transcription by Mutant Derivatives of the Latent Membrane Protein of Epstein-Barr Virus. J. Virol. 69:1995;2968-2976.
29. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr Virus Transforming Protein LMP1 Engages Signaling Proteins for the Tumor Necrosis Factor Receptor Family. Cell. 80:1995;389-399.
30. Nemerow G. R., Cooper N. R. Isolation of Epstein-Barr virus and studies of its neutralization by human IgG and complement. J. Immunol. 127:1981;272-278.
31. Nemerow G. R., Cooper N. R. Early events in the infection of human B lymphocytes by Epstein-Barr virus: The internalization process. Virology. 132:1984;186-198.
32. Reedman B. M., Klein G. Cellular Localization of an Epstein-Barr Virus (EBV)-Associated Complement-Fixing Antigen in Producer and Non-producer Lymphoblastoid Cell Lines. Int. J. Cancer. 11:1973;499-520.
33. Rowe M., Evans H. S., Young L. S., Hennessy K., Kieff E., Rickinson A. B. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J. Gen. Virol. 1987.
34. Rowe M., Lear A. L., Croom-Carter D., Davies A. H., Rickinson A. B. Three pathways of Epstein-Barr virus gene activation from EBNA-1 positive latency in B lymphocytes. J. Virol. 66:1992;122-131.
35. Sample J., Liebowitz D., Kieff E. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J. Virol. 63:1989;933-937.
36. Sinclair A. J., Farrell P. J. Host Cell Requirements for Efficient Infection of Quiescent Primary B Lymphocytes by Epstein-Barr Virus. J. Virol. 69:1995;5461-5468.
37. Spear P. G., Roizman B. Proteins Specified by Herpes Simplex Virus V. Purification and Structural Proteins of the Herpesvirion. J. Virol. 9:1972;143-159.
38. Wang D., Liebowitz D., Kieff E. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J. Virol. 62:1988;2337-2346.
39. Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A., Larson R., Springer T., Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J. Virol. 62:1988;4173-4184.
40. Wang F., Gregory C., Sample C., Rowe M., Liebowitz D., Murray R., Rickinson A., Kieff E. Epstein-Barr Virus Latent Membrane Protein (LMP1) and Nuclear Proteins 2 and 3C Are Effectors of Phenotypic Change in B Lymphoctyes: EBNA-2 and LMP1 Cooperatively Induce CD23. J. Virol. 64:1990;2309-2318.
41. York I. A., Roop C., Andrews D. W., Riddell S. R., Graham F. L., Johnson D. C. A Cytosolic Herpes Simplex Virus protein Inhibits Antigen Presentation to CD8+ T Lymphocytes. Cell. 77:1994;525-535.